Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Recent studies on long-acting GLP-1s in type 1 diabetes have shown promising results, including reductions in A1C levels and increased time within the target blood sugar range, without diabetic ketoacidosis or significant hypoglycemic episodes.It is well-established that elevated A1C levels can increase the risk of cardiovascular complications and kidney disease in individuals with T1D
Lower Leg / Calves
[1] [2] For weight management, Zepbound is indicated for adults with a BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity
Q2 REVENUES/ H1 REVENUES AbbVie reported second-quarter 2026 net revenues of 16.99 billion dollars, up 10.2 percent compared to the same period last year, driven by robust performance from its immunology portfolio
RELATED STORY | Scientists say GLP-1s improved male testosterone levels and sperm count Multiple studies have found that people who take GLP-1 drugs may have a lower risk of developing cancer
